Biotechnology Genscript Biotech has entered into an agreement to acquire 100% of the issued shares of privately held CustomArray that provides customized oligonucleotide pools and microarrays to many of the world's leading academic and industrial organizations for applications in targeted sequencing, complex DNA libraries, synthetic biology, shRNA libraries, and CRISPR. 28 December 2017